. Invention also includes use of compound of formula 1 as an antitumour agent for adjuvant anticancer immunotherapy together with doxorubicin, as well as an antiallergenic preventive agent in seasonal allylic infections. Group of inventions provides higher anti-tumor activity and can be used as an independent anticancer agent and simultaneous increase in the effectiveness of cytostatic treatment of oncological patients.;EFFECT: new agent has no undesirable side effects inherent in fluorinated pyrimidines and anthracycline antibiotics.;3 cl, 5 tbl, 5 ex"/>
公开/公告号RU2686672C1
专利类型
公开/公告日2019-04-30
原文格式PDF
申请/专利号RU20180126831
发明设计人 KOVALENKO LARISA PETROVNA (RU);NIKITIN SERGEJ VASILEVICH (RU);DURNEV ANDREJ DMITRIEVICH (RU);GUDASHEVA TATYANA ALEKSANDROVNA (RU);
申请日2018-07-20
分类号A61K31/505;A61P35;A61P37/08;A61P29;A61P37/02;
国家 RU
入库时间 2022-08-21 11:46:14